NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)
Clinical trial NCT01950689 · COMPLETED
Trial details
- NCT number
- NCT01950689
- Sponsor
- The Christie NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-11
- Primary completion
- 2021-01-07
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.